M.S. Gordon
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Renal and related cancers 14
-
- Renal cell carcinoma treatment 24
- Co-authors
- Patrick J. Loehrer (1 shared paper)Kent C. Shih (1 shared paper)Isabelle Rooney (1 shared paper)Omar Kabbarah (1 shared paper)Darlene Lu (1 shared paper)William W. Ho (1 shared paper)Elaine T. Lam (1 shared paper)Peter H. O’Donnell (1 shared paper)
- Journals
- European Journal of Cancer (2 papers)Therapeutic Drug Monitoring (1 paper)Journal of Clinical Oncology (1 paper)European Journal of Cancer Supplements (7 papers)Yearbook of Oncology (72 papers)
- Partner nations
- United States
In The Last Decade
M.S. Gordon
86 papers receiving 676 citations
Peers
Comparison fields: 5 of 65
- Hematology 217
- Genetics 94
- Oncology 178
- Pulmonary and Respiratory Medicine 207
- Cancer Research 94
Countries citing papers authored by M.S. Gordon
This map shows the geographic impact of M.S. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.S. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.S. Gordon more than expected).
Fields of papers citing papers by M.S. Gordon
This network shows the impact of papers produced by M.S. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.S. Gordon. The network helps show where M.S. Gordon may publish in the future.
Co-authors
The 25 scholars most cited alongside M.S. Gordon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 83 | |
| 2 | 2010 | 39 | |
| 3 | 2008 | 36 | |
| 4 | 2010 | 32 | |
| 5 | 2006 | 30 | |
| 6 | 2007 | 29 | |
| 7 | 2008 | 29 | |
| 8 | 2012 | 28 | |
| 9 | 2010 | 25 | |
| 10 | 2008 | 20 | |
| 11 | 2008 | 19 | |
| 12 | 2008 | 18 | |
| 13 | 2009 | 17 | |
| 14 | 2008 | 15 | |
| 15 | 2009 | 12 | |
| 16 | 1998 | 11 | |
| 17 | 2006 | 11 | |
| 18 | 2009 | 11 | |
| 19 | 2006 | 11 | |
| 20 | 2009 | 11 |
About M.S. Gordon
M.S. Gordon is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Hematology, Oncology and Genetics, having authored 92 papers that have together received 713 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (24 papers), Renal and related cancers (14 papers), Chronic Lymphocytic Leukemia Research (14 papers), Acute Myeloid Leukemia Research (13 papers), Cancer Genomics and Diagnostics (12 papers), Chronic Myeloid Leukemia Treatments (10 papers), Lymphoma Diagnosis and Treatment (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Hematology (217 citations), Genetics (94 citations), Oncology (178 citations), Pulmonary and Respiratory Medicine (207 citations) and Cancer Research (94 citations). M.S. Gordon has collaborated with scholars based in United States. Frequent co-authors include Patrick J. Loehrer, Kent C. Shih, Isabelle Rooney, Omar Kabbarah, Darlene Lu, William W. Ho, Elaine T. Lam, Peter H. O’Donnell, David S. Mendelson and Charles P. Theuer. Their work appears in journals such as European Journal of Cancer, Therapeutic Drug Monitoring, Journal of Clinical Oncology, European Journal of Cancer Supplements and Yearbook of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.